Safety, Blood Levels, Drug Interaction and Effects of Repeated Doses of GSK1034702

Clinical trial NCT00950586 · COMPLETED

Trial details

NCT number: NCT00950586
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Cognitive Disorders

Start date: 2009-08-24
Primary completion: 2009-12-24
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.